Cargando…

Cytosolic phospholipase A(2) (cPLA(2)) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages

BACKGROUND: Smoking is one of the leading causes of millions of deaths worldwide. During cigarette smoking, most affected and highly exposed cells are the alveolar epithelium and generated oxidative stress in these cells leads to death and damage. Several studies suggested that oxidative stress caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Subodh K., Sharma, Sanjeev K., Farooque, Abdullah, Kaushik, Gaurav, Kaur, Balwinder, Pathak, Chander M., Dwarakanath, Bilikere S., Khanduja, Krishan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986351/
https://www.ncbi.nlm.nih.gov/pubmed/27528014
http://dx.doi.org/10.1186/s12944-016-0300-x
_version_ 1782448189590208512
author Yadav, Subodh K.
Sharma, Sanjeev K.
Farooque, Abdullah
Kaushik, Gaurav
Kaur, Balwinder
Pathak, Chander M.
Dwarakanath, Bilikere S.
Khanduja, Krishan L.
author_facet Yadav, Subodh K.
Sharma, Sanjeev K.
Farooque, Abdullah
Kaushik, Gaurav
Kaur, Balwinder
Pathak, Chander M.
Dwarakanath, Bilikere S.
Khanduja, Krishan L.
author_sort Yadav, Subodh K.
collection PubMed
description BACKGROUND: Smoking is one of the leading causes of millions of deaths worldwide. During cigarette smoking, most affected and highly exposed cells are the alveolar epithelium and generated oxidative stress in these cells leads to death and damage. Several studies suggested that oxidative stress causes membrane remodeling via Phospholipase A(2)s but in the case of cigarette smokers, mechanistically study is not yet fully defined. In view of present perspective, we evaluated the involvement of cytosolic phospholipase A(2) (cPLA(2)) IVA as therapeutic target in cigarette smoke induced pathologies in transformed type I and type II alveolar epithelial cells. METHODS: Transformed type I (WI26) and type II (A549) alveolar epithelial cells were used for the present study. Cigarette smoke condensate (CSC) was prepared from most commonly used cigarette (Gold Flake with filter) by the Indian population. CSC-induced molecular changes were evaluated through cell viability using MTT assay, reactive oxygen species (ROS) measurement using 2,7 dichlorodihydrofluorescin diacetate (DCFH-DA), cell membrane integrity using fluorescein diacetate (FDA) and ethidium bromide (EtBr) staining, super oxide dismutase (SOD) levels, cPLA(2) activity and molecular involvement of specific cPLA(2)s at selected 24 h time period. RESULTS: CSC-induced response on both type of epithelial cells shown significantly reduction in cell viability, declined membrane integrity, with differential escalation of ROS levels in the range of 1.5–15 folds and pointedly increased cPLA(2) activity (p < 0.05). Likewise, we observed distinction antioxidant potential in these two types of lineages as type I cells had considerably higher SOD levels when compared to type II cells (p < 0.05). Further molecular expression of all cPLA(2)s increased significantly in a dose dependent manner, specifically cytosolic phospholipase A(2) IVA with maximum manifestation of 3.8 folds. Interestingly, CSC-induced ROS levels and cPLA(2)s expression were relatively higher in A549 cells as compared to WI26 cells. CONCLUSIONS: The present study indicates that among all cPLA(2)s, specific cPLA(2) IVA are the main enzymes involved in cigarette smoke induced anomalies in type I and type II lung epithelial cells and targeting them holds tremendous possibilities in cigarette smoke induced lung pathologies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-016-0300-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4986351
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49863512016-08-17 Cytosolic phospholipase A(2) (cPLA(2)) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages Yadav, Subodh K. Sharma, Sanjeev K. Farooque, Abdullah Kaushik, Gaurav Kaur, Balwinder Pathak, Chander M. Dwarakanath, Bilikere S. Khanduja, Krishan L. Lipids Health Dis Research BACKGROUND: Smoking is one of the leading causes of millions of deaths worldwide. During cigarette smoking, most affected and highly exposed cells are the alveolar epithelium and generated oxidative stress in these cells leads to death and damage. Several studies suggested that oxidative stress causes membrane remodeling via Phospholipase A(2)s but in the case of cigarette smokers, mechanistically study is not yet fully defined. In view of present perspective, we evaluated the involvement of cytosolic phospholipase A(2) (cPLA(2)) IVA as therapeutic target in cigarette smoke induced pathologies in transformed type I and type II alveolar epithelial cells. METHODS: Transformed type I (WI26) and type II (A549) alveolar epithelial cells were used for the present study. Cigarette smoke condensate (CSC) was prepared from most commonly used cigarette (Gold Flake with filter) by the Indian population. CSC-induced molecular changes were evaluated through cell viability using MTT assay, reactive oxygen species (ROS) measurement using 2,7 dichlorodihydrofluorescin diacetate (DCFH-DA), cell membrane integrity using fluorescein diacetate (FDA) and ethidium bromide (EtBr) staining, super oxide dismutase (SOD) levels, cPLA(2) activity and molecular involvement of specific cPLA(2)s at selected 24 h time period. RESULTS: CSC-induced response on both type of epithelial cells shown significantly reduction in cell viability, declined membrane integrity, with differential escalation of ROS levels in the range of 1.5–15 folds and pointedly increased cPLA(2) activity (p < 0.05). Likewise, we observed distinction antioxidant potential in these two types of lineages as type I cells had considerably higher SOD levels when compared to type II cells (p < 0.05). Further molecular expression of all cPLA(2)s increased significantly in a dose dependent manner, specifically cytosolic phospholipase A(2) IVA with maximum manifestation of 3.8 folds. Interestingly, CSC-induced ROS levels and cPLA(2)s expression were relatively higher in A549 cells as compared to WI26 cells. CONCLUSIONS: The present study indicates that among all cPLA(2)s, specific cPLA(2) IVA are the main enzymes involved in cigarette smoke induced anomalies in type I and type II lung epithelial cells and targeting them holds tremendous possibilities in cigarette smoke induced lung pathologies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-016-0300-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-15 /pmc/articles/PMC4986351/ /pubmed/27528014 http://dx.doi.org/10.1186/s12944-016-0300-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yadav, Subodh K.
Sharma, Sanjeev K.
Farooque, Abdullah
Kaushik, Gaurav
Kaur, Balwinder
Pathak, Chander M.
Dwarakanath, Bilikere S.
Khanduja, Krishan L.
Cytosolic phospholipase A(2) (cPLA(2)) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages
title Cytosolic phospholipase A(2) (cPLA(2)) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages
title_full Cytosolic phospholipase A(2) (cPLA(2)) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages
title_fullStr Cytosolic phospholipase A(2) (cPLA(2)) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages
title_full_unstemmed Cytosolic phospholipase A(2) (cPLA(2)) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages
title_short Cytosolic phospholipase A(2) (cPLA(2)) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages
title_sort cytosolic phospholipase a(2) (cpla(2)) iva as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986351/
https://www.ncbi.nlm.nih.gov/pubmed/27528014
http://dx.doi.org/10.1186/s12944-016-0300-x
work_keys_str_mv AT yadavsubodhk cytosolicphospholipasea2cpla2ivaasapotentialsignaturemoleculeincigarettesmokecondensateinducedpathologiesinalveolarepitheliallineages
AT sharmasanjeevk cytosolicphospholipasea2cpla2ivaasapotentialsignaturemoleculeincigarettesmokecondensateinducedpathologiesinalveolarepitheliallineages
AT farooqueabdullah cytosolicphospholipasea2cpla2ivaasapotentialsignaturemoleculeincigarettesmokecondensateinducedpathologiesinalveolarepitheliallineages
AT kaushikgaurav cytosolicphospholipasea2cpla2ivaasapotentialsignaturemoleculeincigarettesmokecondensateinducedpathologiesinalveolarepitheliallineages
AT kaurbalwinder cytosolicphospholipasea2cpla2ivaasapotentialsignaturemoleculeincigarettesmokecondensateinducedpathologiesinalveolarepitheliallineages
AT pathakchanderm cytosolicphospholipasea2cpla2ivaasapotentialsignaturemoleculeincigarettesmokecondensateinducedpathologiesinalveolarepitheliallineages
AT dwarakanathbilikeres cytosolicphospholipasea2cpla2ivaasapotentialsignaturemoleculeincigarettesmokecondensateinducedpathologiesinalveolarepitheliallineages
AT khandujakrishanl cytosolicphospholipasea2cpla2ivaasapotentialsignaturemoleculeincigarettesmokecondensateinducedpathologiesinalveolarepitheliallineages